Effects of Prostacyclin Infusion on Platelet Activation and Postoperative Blood Loss in Coronary Bypass
|
|
- Julius Sparks
- 5 years ago
- Views:
Transcription
1 Effects of Prostacyclin Infusion on Platelet Activation and Postoperative Blood Loss in Coronary Bypass Claes Aren, M.D., Kurt Feddersen, M.D., and Kjell Ridegran, M.D. ABSTRACT The effects of infusion of prostacyclin were studied in 41 patients undergoing aortocoronary bypass. Twenty-three patients received heparin (2 mg per kilogram of body weight) and prostacyclin (50 ng per kilogram per minute) during cardiopulmonary bypass (CPB). Eighteen patients received heparin (3 mg per kilogram). One hour after CPB, the platelet count was 98 * 16% of the value obtained before CPB in the prostacyclin group and 73 * 18% in the control group (p < 0.001). The plasma level of platelet factor 4 rose only initially during CPB in the prostacyclin group, but increased continuously in the control group; at 90 minutes of CPB it was 92 * 35 ng per milliliter and 376 * 119 ng per milliliter, respectively (p < 0.001). Beta-thromboglobulin showed a similar pattern. Postoperative chest drainage was 386? 87 ml in the prostacyclin group and ml in the control group (p < 0.05). Blood transfused during and five days after operation was 1,359 * 751 ml in the prostacyclin group and 2,047 * 915 ml in the control group (p < 0.05). During cardiopulmonary bypass (CPB) the blood is exposed to the artificial surfaces of the extracorporeal circuit, including the blood-gas interface in the bubble oxygenator. Such exposure leads to activation of the platelets followed by morphological changes, release of substances from subcellular granules, and formation of platelet aggregates. Platelet aggregates are removed from the circulation [l], and the remaining circulating platelets often demonstrate impaired function [2]. This disturbance of platelet function may contribute to postoperative hemorrhage. From the Departments of Thoracic Surgery and Anesthesiology, Sahlgrenska sjukhuset, Goteborg, Sweden. Accepted for publication Sept 28, Address reprint requests to Dr. Ridegran, Department of Thoracic Surgery, Sahlgrenska sjukhuset, S Goteborg, Sweden. Inhibition by pharmacological means of platelet activation during CPB might protect the platelets and leave their hemostatic capacity intact for use after bypass. For this purpose, prostacyclin may be the best platelet inhibitor yet discovered. Also, it is rapidly broken down in vivo and its effects on the platelets are shortlived. We and others [3-51 have shown that infusion of prostacyclin reduces the decrease in platelet count during CPB. Platelet activation is accompanied by release of two platelet-specific proteins, platelet factor 4 and beta-thromboglobulin, into the plasma [6]. The plasma levels of these two proteins may thus be used as indicators of platelet activation. We decided to study whether infusion of prostacyclin results in less platelet activation as measured by the release of platelet factor 4 and beta-thromboglobulin and whether this would be accompanied by a reduction in postoperative blood loss. We found that infusion of prostacyclin during CPB significantly inhibited the increases in plasma of the two platelet-specific proteins, and reduced postoperative blood loss and the amount of blood and blood products needed for transfusion. The study was approved by the Ethics Committee of the Sahlgrenska sjukhuset. Material and Methods The investigation comprised 41 patients (numbered 9 through 49 in our ongoing studies) who underwent aortocoronary bypass during the period October, 1980, to January, 1982 (Table l). No patients were studied between February and September, 1981, because of the unavailability of prostacyclin. No patient had taken any drug known to affect platelet function within five days prior to operation. The patients were randomly divided into two groups. Eighteen patients received heparin, 3 mg per kilogram of body weight, before CPB and served as a control group. Twenty-three pa- 49
2 50 The Annals of Thoracic Surgery Vol 36 No 1 July 1983 Table 1. Data on the Two Groups of Patients" Variable Control Group Prostacyclin Group Mentwomen Age (yr) 56? 9 56? 8 Weight (kg) 82? f 10 Peripheral anastomoses 3.6 * ? 1.1 CPB (min) 132? ? 30 End of CPB to sternum closure (min) 83 f f 10 "Where applicable, data are shown as mean k standard deviation. CPB = cardiopulmonary bypass. tients received heparin, 2 mg per kilogram, before CPB and prostacyclin, 50 ng per kilogram per minute in the extracorporeal circuit, from the start of CPB until 10 minutes before its termination. Prostacyclin (Cyclo-Prostin, synthesized by the Upjohn Company and formulated by the Wellcome Foundation) was dissolved in a glycine buffer, ph Anesthesia was initiated with thiopental, administered intravenously, and maintained with fentanyl, also given intravenously, and inhalation of oxygen plus nitrous oxide. Extracorporeal circulation was by roller pump and a Polystan VT 7000 bubble oxygenator in the first 20 patients and a Harvey H-1500 bubble oxygenator in the last 21 patients. Priming was with Ringer's acetate, to which was added 75 mg of heparin. There was no arterial line filter. Cardiotomy suction was used freely. A Polystan 444 cardiotomy reservoir, containing a 40 p filter, was used. Hypothermia to 28 C was induced, and the blood flow at this temperature was reduced to 40 to 45 ml per kilogram per minute. Anticoagulation was checked intraoperatively by the activated clotting time using a Hemochron.* The same device was used in all patients. If the activated clotting time was less than 350 seconds, small additional doses of heparin were given. After CPB was terminated, protamine chloride was given to both groups in a 1:l ratio to injected heparin. Seventy-five percent of this dose was given shortly after discontinuance of bypass and the remainder, after *International Technidyne Corp., Metuchen, NJ transfusion of all blood from the extracorporeal circuit. Blood samples were drawn by direct needle puncture of a peripheral vein before initiation of anesthesia and by puncture of the right atrial appendage before arid 60 minutes after CPB. Samples were taken from the venous line of the extracorporeal circuit after 10 and 30 minutes of bypass and then at.30-minute intervals. Measurements were made of hematocrit, platelet count in whole blood," activated clotting time (Hemochron), and heparin by a chromogenic substrate method [7, 81. In the last 16 patients of the series, 9 in the prostacyclin group and 7 in the control group, measurements were also made of platelet factor 4 and beta-thromboglobulin in plasma. For these determinations. 4.5 ml blood was drawn into siliconized glass tubest containing 0.5 ml of a solution of 3.3 gm of sodium ethylenediaminetetraacetate, 180 mg of theophylline, and 0.33 pg of prostaglandin El per 100 ml of distilled water, p1-i 7.3. The samples were stored immediately on ice and centrifuged at 4 C and 2,000 x g within two hours. The supernatant was then frozen and stored at - 20 C until analysis. Commercially available radioimmunoassay kits were used for measurements of platelet factor 4$ and beta-thromboglobulin. The drainage from the chest tubes was measured from the end of the operation to 6:OO A.M. the following day. It was collected in a bottle containing 100 ml of 0.1% chlorhexidine solution. The hemoglobin concentration of the bottle content was deterinined, and a recalculation of the drainage volume, for a common hemoglobin value of 100 gm per liter, was performed. In order to standardize the surgical procedure, all patients were operated on by the same two surgeons (K. R. and C. A.). The period of surgical hemostasis, i.e., from the end of CPB to closure of the sternum, was determined (see Table 1). Because of the blood sampling protocol, this period could not be less than 60 minutes. *Ultra-Flo 100; Clay Adam. Division of Becton, Dickinson & Company, Parsippany, NJ. 'Venoject; Kimble-Terumo Inc., Elkton, MD. iabbott Laboratories Diaanostic - Division, Abbott Park, N Chicago, IL. Amenham International Limited, Amersham, UK
3 51 Aren, Feddersen, and Ridegran: Effects of Prostacyclin Infusion in Coronary Bypass Records were kept of transfusions of blood and blood products during operation, from the end of operation to 6:OO A.M. the following day, and postoperatively including the fifth postoperative day. A systolic arterial blood pressure of less than 100 mm Hg together with a low pulmonary capillary wedge pressure or diastolic pulmonary pressure was considered an indication for volume substitution with whole blood or plasma. A hemoglobin concentration of less than 100 gm per liter was considered an indication for transfusion of packed red cells. Infusion of crystalloid solutions, including the priming solution, was measured and urinary output determined during and after operation until 6:OO A.M. the following day. All data are reported as mean 2 standard deviation. Significance testing was by the twotailed Mann-Whitney test. A p value less than 0.05 was considered to indicate a significant difference. Results One patient in the control group had a myocardial infarction on the fourth postoperative day and died. There were no hospital deaths in the group given prostacyclin. The platelet count, corrected for hematocrit, was significantly higher in the prostacyclin group than in the control group from 60 minutes of bypass onward (Fig 1). Sixty minutes following CPB, the platelet count was % of the value obtained before bypass in the control group compared with 98 t 16% in the prostacyclin group. The plasma levels of platelet factor 4 and betathromboglobulin did not change significantly during the period before the induction of anesthesia to immediately before the start of CPB. During CPB there was a continuous rise in the levels of platelet factor 4 and beta-thromboglobulin in the control group (Figs 2, 3). In contrast, there was only an initial, small increase in the levels in the prostacyclin group. Sixty minutes after CPB, platelet factor 4, but not beta-thromboglobulin, had returned to levels similar to those measured before bypass in both groups. Concentration of heparin decreased slightly in both groups during CPB (Fig 4). The need for 6W PTC % of pre-cpb value * t * x* *** *** *** 120 J I T (I/ 20.,.,.,,, ~ PRE mln 60 min CPB of CPB after CPB Fig 1. Platelet count (PTC), corrected for hemodilufion, during and an hour after cardiopulmonay bypass (CPB) Data are shown as mean? standard deviation. (0 = control group; 0 = prostacyclin group; * = p < 0.05; *** = p < ) 1 \ PRE PRE ANEST CPE I I 120rnm of CPE 60mm after CPE Fig 2. Concentration of plasma platelet factor 4 (PF 4) before anesthesia (PRE ANEST), before start of cardiopulmonary bypass (PRE CPB), during CPB, and an hour after CPB. Data are shown as mean? standard deviation. (0 = control group; o = prostacyclin group; * = p < 0.05; ** = p < 0.02; *** = p < ) supplementary heparin was greater in the control group in which 12 out of 18 patients received extra heparin. In comparison, only 2 out of 23 patients in the prostacyclin group required additional heparin. Activated clotting time was greatly prolonged in the prostacyclin group in comparison with the control group early during CPB. However, the difference disappeared after two hours of CPB (Fig 5).
4 52 The Annals of Thoracic Surgery Vol 36 No 1 July 1983 R-TG ng ml-1 * *** *** *** *** ACT sec,ooo] LOO I, I t, 1 PRE PRE min 60mm ANEST CPB of CPB afiercpb Fig 3. Concentration of plasma beta-thromboglobulin (p- TG) before anesthesia (PRE ANEST), before start of cardiopulmonary bypass (PRE CPB), during CPB, and an hour after CPB. Data are shown as mean * standard deviation. (0 = control group; o = prostacyclin group; * = p < 0.05; *** = p < ) - I PRE rnm 60 rnm CPB of CPB aftercpb Fig 5. Activated clotting time (ACT) before cardiopulmonay bypass (PRE CPB), during CPB, and an hour after CPB. Data are shown as mean * standard deviation. (0 = control group; 0 = prostacyclin group.) HEPARIN A IU ml-1 tion of the drainage volumes to a common hemoglobin concentration of 100 gm per liter yielded 163 * 63 ml in the prostacyclin group and 380 k 280 ml in the control group (p < 0.05), a savings of 57%. The patients in the prostacyclin group received significantly less blood and blood products than those in the control group early postoperatively, as well as totally during and after operation (Table 2). The infusion of crystalloid solutions (including the priming and cardioplegic solutions) during operation and up to 6:OO A.M. the following day was 8.6 f 2.3 liters in the control group and of CPB after CPB Fig 4. Plasma concentration of heparin during cardiopulmonay bypass (CPB) and an hour after CPB. Data are shown as mean f standard deviation. (0 = control group; o = prostacyclin group.) 7.6 & 1.7 liters in the prostacyclin group. The urinary output during; this period was liters in the control group and 3.8 f 1.0 liters in the group given prostacyclin. Chest drainage from the end of operation to 6:OO A.M. the following day was 386? 87 ml in the prostacyclin group compared with 596 & 342 ml in the control group (p < 0.05), a savings of 35%. One patient in the control group was reoperated on for bleeding. Only the chest drainage up to reoperation (1,475 ml) was included in the chest drainage calculation for the control group. No surgical explanation for the bleeding was found at exploration. Recalcula- Comment During CPB there usually occurs a drop in platelet count [2] and a release of constituents from subcellular platelet granules [9]. In the present study, infusion of prostacyclin significantly reduced the drop in platelet count and the release of platelet factor 4 and betathromboglobulin. This demonstrates an inhibitory effect on platelet activation by prostacyclin during CPB. To achieve maximum platelet inhibition at the start of CPB, it might be advantageous to begin the infusion of prostacyclin early in the operation. This might also counteract the
5 53 Aren, Feddersen, and Rbdegran: Effects of Prostacyclin Infusion in Coronary Bypass Table 2. Intraoperative and Postoperative Transfusions Control Group Prostacyclin Group Period (ml) (ml) Significance During operation End of operation to day 1 Days 1-5 Total 625 * 601 1,076 1? ? 397 2,047 * 915 adata are shown as mean? standard deviation. NS = not significant ? & ? 555 1,359 1?1 751 NS p < 0.01 NS p < 0.05 platelet aggregation induced by heparin itself [lo]. Such a protocol has been used [3, 11, 121, but the drop in platelet count early during CPB still occurred. However, the dosages of prostacyclin utilized during CPB in these studies were only 20 to 25 ng per kilogram per minute. Inconsistent protection of the platelet count has been reported with infusions of up to 20 ng per kilogram per minute [ 131. The heparin-sparing effect of prostacyclin was confirmed in this study. We [4] suggested in a previous report that this effect might be due to inhibition of the release of the antiheparin factor platelet factor 4, which was confirmed in the present study. However, the activated clotting time, which is strongly affected by prostacyclin j4], was used as the guide for heparin supplementation. This is the major explanation for the heparin-sparing effect. In our study, the pharmacological inhibition of platelets during CPB was associated with beneficial clinical effects. Chest drainage from the end of the operation to 6:OO A.M. the next day was lower and also varied less in the prostacyclin group than in the control group. Since the chest drainage is composed of both blood and tissue fluid, we measured its hemoglobin concentration. When the drained volume was recalculated to a common hemoglobin value of 100 gm per liter, we found that not only was the drained volume lower in the prostacyclin group, but that it also contained less blood than in the control group. A saving of blood on the order of a few hundred milliliters may not seem impressive, but this study was performed with patients undergoing coronary bypass, patients with the fewest problems in terms of bleeding. More pronounced differences might be expected in other categories of patients in whom major bleeding is more commonplace such as those with congenital cyanotic heart disease or those requiring reoperations. Differences in blood loss might be due to surgical technique. In an attempt to reduce such a bias, all patients were operated on by the same two surgeons. The technique used for surgical hemostasis and the time spent on hemostasis were strictly standardized. The amount of blood and blood products transfused intraoperatively and postoperatively was significantly less in the prostacyclin group. It amounted to a savings of 700 ml, which, in fact, is greater than the reduction in chest drainage. Although the water balance was somewhat more positive in the prostacyclin group, this was hardly of a magnitude to explain the difference. Effects on vascular tone by vasoactive substances such as epinephrine, norepinephrine, vasopressin, and angiotensin must also be taken into account. When analyzing the figures in Table 2, it should be noted that 400 to 500 ml of blood was drawn from the patients for all the laboratory tests included in this and coupled studies. The use of an infusion of prostacyclin of 50 ng per kilogram per minute during CPB results in a mean arterial blood pressure of about 30 mm Hg during the first hour of CPB [4]. It might be argued that whatever beneficial effects this infusion may have on postoperative blood loss and blood requirements, such a low blood pressure is too hazardous to justify the use of prostacyclin in this dosage. However, low blood pressure has not been associated with an in-
6 54 The Annals of Thoracic Surgery Vol 36 No 1 July 1983 creased incidence of postoperative organ dysfunction in the present study or in a previous study by one of us [3]. We conclude that infusion of prostacyclin significantly reduced platelet activation during CPB. This resulted in lower postoperative blood loss and less need for transfusion of blood and blood products. This study was supported by Grant No. B83-17X from the Swedish Medical Research Council, the Goteborg Medical Society, and the Upjohn Company. References 1. Hope AF, Heyns AduP, Lotter MG, et al: Kinetics and sites of sequestration of indium 111-labeled human platelets during cardiopulmonary bypass. J Thorac Cardiovasc Surg 81:880, Friedenburg WR, Myers WO, Plotka ED, et al: Platelet dysfunction associated with cardiopulmonary bypass. Ann Thorac Surg 25:298, Longmore DB, Bennet G, Hoyle PM, et al: Prostacyclin administration during cardiopulmonary bypass in man. Lancet 1:800, Ridegran K, Aren C, Teger-Nilsson A-C: Prostacyclin infusion during extracorporeal circulation for coronary bypass. J Thorac Cardiovasc Surg 83:205, Ridegran K, Egberg N, Papaconstantinou C: Effects of prostacyclin {during cardiopulmonary bypass in man. Scand J Thorac Cardiovasc Surg 15:263, Niewiarowski S: Proteins secreted by the platelet. Thromb Haemost 38:924, Odegird OR, Lie M, Abildgaard U: Heparin cofactor activity measured with an amidolytic method. Thromb Res 6:287, Teien AN, Lie M, Abildgaard U: Assay of heparin in plasma using a chromogenic substrate for activated factor X. Thromb Res 8:413, Cella G, Vittadello 0, Gallucci V, Girolami A: The release of beta-throntboglobulin and platelet factor 4 during extracorporeal circulation for open heart surgery. Eur J Clin Invest 11:165, Eika C: The platelet aggregating effect of eight commercial heparins. Scand J Haematol 9:480, Bunting S, O Grady I, Fabini JN, et al: Cardiopulmonary bypass in man: effects of prostacyclin. In Lewis PJ, O Grady J (eds): Clinical Pharmacology of Prostacyclin. New York, Raven, 1981, pp Walker ID, Davidson JF, Faichney A, et al: Prostacyclin in cardiopulmonary bypass surgery. In Lewis PJ, O Grady J (eds): Clinical Pharmacology of Prostacyclin. New York, Raven, 1981, pp Ridegran K, Papaconstantinou C: Prostacyclin infusion during cardiopulmonary bypass in man. Thromb Res 19:267, 1980
Requirement in Coronary Bypass Surgery
Blood Loss and Bank Blood Requirement in Coronary Bypass Surgery Thomas Yeh, Jr., Larry Shelton, C.C.P., and Thomas J. Yeh, M.D. ABSTRACT With the use of nonblood prime and refinement in perfusion and
More informationTransfusion and Blood Conservation
Transfusion and Blood Conservation Kenneth G. Shann, CCP Assistant Director, Perfusion Services Senior Advisor, Performance Improvement Department of Cardiovascular and Thoracic Surgery Montefiore Medical
More informationOPCABG for Full Myocardial Revascularisation How we do it
OPCABG for Full Myocardial Revascularisation How we do it 28 th SHA Conferance Dr.Farouk Oueida Head of Cardiac Surgery Dept. SBCC-Dammam KSA The Less Invasive CABG Full Revascularisation Full Sternotomy
More informationECMO vs. CPB for Intraoperative Support: How do you Choose?
ECMO vs. CPB for Intraoperative Support: How do you Choose? Shaf Keshavjee MD MSc FRCSC FACS Director, Toronto Lung Transplant Program Surgeon-in-Chief, University Health Network James Wallace McCutcheon
More informationUnderstanding the Cardiopulmonary Bypass Machine and Its Tubing
Understanding the Cardiopulmonary Bypass Machine and Its Tubing Robert S. Leckie, MD Division of Cardiac Anesthesia, Beth Israel Deaconess Medical Center ABL 1/09 Reservoir Bucket This is a cartoon of
More informationIntra-operative Effects of Cardiac Surgery Influence on Post-operative care. Richard A Perryman
Intra-operative Effects of Cardiac Surgery Influence on Post-operative care Richard A Perryman Intra-operative Effects of Cardiac Surgery Cardiopulmonary Bypass Hypothermia Cannulation events Myocardial
More informationAugust, 2015 STATE MEDICAL FACULTY OF WEST BENGAL. Preliminary Examinations for Diploma in Perfusion Technology : DPfT. Paper I ANATOMY & PHYSIOLOGY
August, 2015 STATE MEDICAL FACULTY OF WEST BENGAL Paper I ANATOMY & PHYSIOLOGY Time 3 hours Full Marks 80 Group A Q-1) Write the correct Answer: 10x1 = 10 i) The posterior descending artery is branch of
More informationGoals and Objectives. Assessment Methods/Tools
CA-2 CARDIOTHORACIC ANESTHESIA ROTATION Medical Center Fairview (UMMC) Rotation Site Director: Drs. Ioanna Apostolidou & Douglas Koehntop Rotation Duration: 6 weeks Introduction: The overall goal of the
More informationCardiac anaesthesia. Simon May
Cardiac anaesthesia Simon May Contents Cardiac: Principles of peri-operative management for cardiac surgery Cardiopulmonary bypass, cardioplegia and off pump cardiac surgery Cardiac disease and its implications
More informationCCAS CPB Workshop Curriculum Outline Perfusion: What you might not know
CCAS CPB Workshop Curriculum Outline Perfusion: What you might not know Scott Lawson, CCP Carrie Striker, CCP Disclosure: Nothing to disclose Objectives: * Demonstrate how the cardiopulmonary bypass machine
More informationClinical Performance of Microporous Polypropylene Hollow-Fiber Oxygenator
Clinical Performance of Microporous Polypropylene Hollow-Fiber Oxygenator Kozo Suma, M.D., Takayuki Tsuji, M.D., Yasuo Takeuchi, M.D., Kenji Inoue, M.D., Kenji Shiroma, M.D., Tetsuo Yoshikawa, M.D., and
More informationBlood Management of the Cardiac Patient in the Postoperative Period
Blood Management of the Cardiac Patient in the Postoperative Period Al Stammers, MSA, CCP, Eric Tesdahl, PhD Andy Stasko MS, CCP, RRT, Linda Mongero, BS, CCP, Sam Weinstein, MD, MBA Goal To examine the
More informationComparison of Flow Differences amoiig Venous Cannulas
Comparison of Flow Differences amoiig Venous Cannulas Edward V. Bennett, Jr., MD., John G. Fewel, M.S., Jose Ybarra, B.S., Frederick L. Grover, M.D., and J. Kent Trinkle, M.D. ABSTRACT The efficiency of
More informationCardiothoracic Fellow Expectations Division of Cardiac Anesthesia, Beth Israel Deaconess Medical Center
The fellowship in Cardiothoracic Anesthesia at the Beth Israel Deaconess Medical Center is intended to provide the foundation for a career as either an academic cardiothoracic anesthesiologist or clinical
More informationPlatelet Loss during Experimental Cardiopulmonary Bypass and Its Prevention with Prostacyclin
Platelet Loss during Experimental Cardiopulmonary Bypass and Its Prevention with Prostacyclin John R. Plachetka, Pharm.D., Neal W. Salomon, M.D., Douglas F. Larson, M.S., and Jack G. Copeland, M.D. ABSTRACT
More informationDemonstration of Uneven. the infusion on myocardial temperature was insufficient
Demonstration of Uneven in Patients with Coronary Lesions Rolf Ekroth, M.D., HAkan erggren, M.D., Goran Sudow, M.D., Josef Wojciechowski, M.D., o F. Zackrisson, M.D., and Goran William-Olsson, M.D. ASTRACT
More informationPerfusion for Repair of Aneurysms of the Transverse Aortic Arch
technique This new section is open for technicians to explore the unusual, the difficult, the innovative methods by which perfusion meets the challenge of the hour and produces the ultimate goal - a life
More informationThe Efficacy of Low Prime Volume Completely Closed Cardiopulmonary Bypass in Coronary Artery Revascularization
Original Article The Efficacy of Low Prime Volume Completely Closed Cardiopulmonary Bypass in Coronary Artery Revascularization Hideaki Takai, MD, Kiyoyuki Eishi, MD, Shiro Yamachika, MD, Shiro Hazama,
More informationCerebral Complication after Open Heart Surgery
Cerebral Complication after Open Heart Surgery Nongchana Klangsuk, Vipa Suparnakui,Somsak Nakdit, Suree Athapaisal, and Pantpis Sakornpant Rajvithi Hospital Bangkok, Thailand Keywords: acid base balance;
More informationSolution for cardiac perfusion in viaflex plastic container
CARDIOPLEGIA SOLUTION A Solution for cardiac perfusion in viaflex plastic container DESCRIPTION Cardioplegia Solution A is a sterile, non-pyrogenic solution in a Viaflex bag. It is used to induce cardiac
More informationHEALTHCARE-ASSOCIATED INFECTIONS How effective is public reporting?
November/December 2013 Volume 10, Issue 6 HEALTHCARE-ASSOCIATED INFECTIONS How effective is public reporting? Best Practices in Blood Management Biomedical Device Integration Brain Science and Patient
More informationGoing on Bypass. What happens before, during and after CPB. Perfusion Dept. Royal Children s Hospital Melbourne, Australia
Going on Bypass What happens before, during and after CPB. Perfusion Dept. Royal Children s Hospital Melbourne, Australia Circulation Brain Liver Kidneys Viscera Muscle Skin IVC, SVC Pump Lungs R.A. L.V.
More informationSredišnja medicinska knjižnica
Središnja medicinska knjižnica Petričević M., Biočina B., Boban M., Zrno Mihaljević M., White A., Rotim C., Subašić A., Miličić Davor. (2015) Clinical relevance and practical value of platelet function
More informationI bypass (CPB) circuit causes platelet damage and impairment
Aprotinin Reduces Intraoperative and Postoperative Blood Loss in Membrane Oxygenator Cardiopulmonary Bypass Marcel P. Harder, MD, Leon Eijsman, MD, Klaas J. Roozendaal, MD, Willem van Oeveren, PhD, and
More informationNitroglycerin and Heparin Drip Interfacility Protocols
Nitroglycerin and Heparin Drip Interfacility Protocols EMS Protocol This protocol applies to nitroglycerin and Heparin drips that are initiated at the transferring facility prior to transport and are not
More informationCardiopulmonary Bypass in Cyanotic Patients. A Review of the Problems and Suggested Strategies
Cardiopulmonary Bypass in Cyanotic Patients A Review of the Problems and Suggested Strategies Extra-ordinary Problems Encountered During C.P.B. for Cyanotic Heart Disease 1. Extra Dilutional Requirements
More informationExam 3 Study Guide. 4) The process whereby the binding of antibodies to antigens causes RBCs to clump is called:
Exam 3 Study Guide 1) Where does hematopoiesis produce new red blood cells: 2) Which of the following is a blood clotting disorder: 3) Treatment of hemophilia often involves: 4) The process whereby the
More informationPulmonary Valve Replacement
Pulmonary Valve Replacement with Fascia Lata J. C. R. Lincoln, F.R.C.S., M. Geens, M.D., M. Schottenfeld, M.D., and D. N. Ross, F.R.C.S. ABSTRACT The purpose of this paper is to describe a technique of
More informationAlternative Anticoagulation during Cardiovascular Procedures in Pediatric Patients with Heparin-Induced Thrombocytopenia
The Journal of ExtraCorporeal Technology Alternative Anticoagulation during Cardiovascular Procedures in Pediatric Patients with Heparin-Induced Thrombocytopenia I. Ricardo Argueta-Morales, MD; Monica
More informationNURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS EPTIFIBATIDE (INTEGRILIN) PROTOCOL
NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE S EPTIFIBATIDE (INTEGRILIN) I. PURPOSE: A. Integrilin (Eptifibatide) is a specific and potent inhibitor of the platelet receptor glycoprotein
More informationE associated with many pathophysiological changes
Quantitation of Particulate Microemboli During Cardiopulmonary Bypass: Experimental and Clinical Studies JinFeng Liu, MD, ZhaoKang Su, MD, and WenXiang Ding, MD Department of Pediatric Cardiothoracic Surgery,
More informationCardiac surgery is associated with a high incidence of
Retrograde Autologous Priming of the Cardiopulmonary Bypass Circuit Reduces Blood Transfusion After Coronary Artery Surgery Subramaniam Balachandran, FRCA, Michael H. Cross, FRCA, Sivagnanam Karthikeyan,
More informationMirsad Kacila*, Katrin Schäfer, Esad Subašić, Nermir Granov, Edin Omerbašić, Faida Kučukalić, Ermina Selimović-Mujčić
& Influence of Two Different Types of Cardioplegia on Hemodilution During and After Cardiopulmonary Bypass, Postoperative Chest-Drainage Bleeding and Consumption of Donor Blood Products Mirsad Kacila*,
More informationHow can ROTEM testing help you in cardiac surgery?
How can ROTEM testing help you in cardiac surgery? Complicated bleeding situations can appear intra and post operatively. They can be life-threatening and always require immediate action. A fast differential
More informationIs the patient at risk for blood loss of 1000 mls? Avoid these Guidelines. Avoid these Guidelines. Yes. Yes. Yes. Yes. Yes
Clinical Guidelines Acute rmovolemic Hemodilution Guidelines for Cardiac Surgery Department of Anesthesiology and Perioperative Medicine Date: 12-30-2012 Is the patient at risk for blood loss of 1000 mls?
More informationNavigating the Dichotomies Between Literature and Your Clinical Practice
Navigating the Dichotomies Between Literature and Your Clinical Practice Robert Groom, CCP, FPP Cardiovascular Institute at Maine Medical Center Disclosures No relevant conflicts related to this presentation
More informationPHENTOLAMINE MESYLATE INJECTION SANDOZ STANDARD 5 mg/ ml THERAPEUTIC CLASSIFICATION Alpha-adrenoreceptor Blocker
PACKAGE INSERT Pr PHENTOLAMINE MESYLATE INJECTION SANDOZ STANDARD 5 mg/ ml THERAPEUTIC CLASSIFICATION Alpha-adrenoreceptor Blocker ACTIONS AND CLINICAL PHARMACOLOGY Phentolamine produces an alpha-adrenergic
More informationTaniguchi, Kazuo; Honda, Natsuo. Citation Acta medica Nagasakiensia. 1990, 35
NAOSITE: Nagasaki University's Ac Title Author(s) ADH Responses to Thoracic and Abdom Anesthesia Noguchi, Takayuki; Yamamori, Shinic Taniguchi, Kazuo; Honda, Natsuo Citation Acta medica Nagasakiensia.
More informationRX; Terumo, Tokyo, Japan). A standard thora- Mitral valve repair in dogs with MR has been
Echocardiographic evaluation of mitral regurgitant volume after mitral valve repair in dogs Y Nakamura et al. months [16] after the surgery. RX; Terumo, Tokyo, Japan). A standard thora- Mitral valve repair
More information12/1/2009. Chapter 19: Hemorrhage. Hemorrhage and Shock Occurs when there is a disruption or leak in the vascular system Internal hemorrhage
Chapter 19: Hemorrhage Hemorrhage and Shock Occurs when there is a disruption or leak in the vascular system External hemorrhage Internal hemorrhage Associated with higher morbidity and mortality than
More informationPostoperative Management of Patients Following Surgical Ablation
Postoperative Management of Patients Following Surgical Ablation Harold G. Roberts, Jr. Department of Cardiovascular and Thoracic Surgery West Virginia University Morgantown, WV None Disclosures Postop
More informationUnrestricted. Dr ppooransari fellowship of perenatalogy
Unrestricted Dr ppooransari fellowship of perenatalogy Assessment of severity of hemorrhage Significant drops in blood pressure are generally not manifested until substantial bleeding has occurred, and
More informationThe Effects of Cardiopulmonary Bypass with Hollow Fiber Membrane Oxygenator on Blood Clotting Measured by Thromboelastography
Physiol. Res. 51: 145-150, 2002 The Effects of Cardiopulmonary Bypass with Hollow Fiber Membrane Oxygenator on Blood Clotting Measured by Thromboelastography M. HORÁČEK, K. CVACHOVEC Department of Anesthesiology
More informationMechanical Bleeding Complications During Heart Surgery
Mechanical Bleeding Complications During Heart Surgery Arthur C. Beall, Jr., M.D., Kenneth L. Mattox, M.D., Mary Martin, R.N., C.C.P., Bonnie Cromack, C.C.P., and Gary Cornelius, C.C.P. * Potential for
More informationThe control patients had at least the combination of cardiovascular failure necessitating vasoactive
ELECTRONIC SUPPLEMENTARY MATERIAL Material and methods Patients The control patients had at least the combination of cardiovascular failure necessitating vasoactive medication, respiratory failure necessitating
More informationECMO CPR. Ravi R. Thiagarajan MBBS, MPH. Cardiac Intensive Care Unit
ECMO CPR Ravi R. Thiagarajan MBBS, MPH Staff Intensivist Cardiac Intensive Care Unit Children s Hospital Boston PCICS 2008, Miami, FL No disclosures Disclosures Outline Outcomes for Pediatric in-hospital
More informationPatient. Venous reservoir. Hemofilter. Heat exchanger. Pump mode. Oxygenator. CHAPTER II - Extracorporeal Circulation (ECC)
CHAPTER II - Extracorporeal Circulation (ECC) ECC is a complex method that allows substitution, for a certain period of time,of heart and lung functions: circulation, gas exchange, acid-base balance, regulation
More informationOstium primum defects with cleft mitral valve
Thorax (1965), 20, 405. VIKING OLOV BJORK From the Department of Thoracic Surgery, University Hospital, Uppsala, Sweden Ostium primum defects are common; by 1955, 37 operated cases had been reported by
More informationLow Dose versus High Dose Heparinization during Post Cardiotomy ECMO: A Case Control Study Disclosures Introduction
Low Dose versus High Dose Heparinization during Post Cardiotomy ECMO: A Case Control Study Vanessa Arnold, BS Mindy M Blackwell, MS, CCP Perfusion Technology Program College of Health Sciences Rush University
More informationWithin coronary patients, those who are affected by
The Role of Antithrombin III in the Perioperative Management of the Patient With Unstable Angina Marco Rossi, MD, Lorenzo Martinelli, MD, Sergio Storti, MD, Michele Corrado, MD, Roberto Marra, MD Carmelita
More informationThe Treatment of Postperfusion Bleeding Using wlminocaproic Acid, Cryoprecipitate, Fresh-Frozen Plasma, and Protamine Sulfate
The Treatment of Postperfusion Bleeding Using wlminocaproic Acid, Cryoprecipitate, Fresh-Frozen Plasma, and Protamine Sulfate Cary J. Lambert, M.D., Alain J. Marengo-Rowe, M.D., James E. Leveson, Ph.D.,
More informationCASE REPORT. Mycotic Aneurysm of Ascending Aorta Due to Sarcina Lutea. G. A. Lopez, M.D., and A. R. C. Dobell, M.D.
CASE REPORT Mycotic Aneurysm of Ascending Aorta Due to Sarcina Lutea G. A. Lopez, M.D., and A. R. C. Dobell, M.D. ABSTRACT A patient developed a mycotic aneurysm of the aortic suture line after aortic
More informationOPJS UNIVERSITY,CHURU(RAJASTHAN) SYLLABUS FOR DIPLOMA IN CARDIAC PERFUSION TECHNOLOGY (DCPT)
OPJS UNIVERSITY,CHURU(RAJASTHAN) SYLLABUS FOR DIPLOMA IN CARDIAC PERFUSION TECHNOLOGY (DCPT) * SCHOOL OF PARA MEDICAL SCIENCE OPJS UNIVERSITY, CHURU (RAJASTHAN) 2013-14 ~*~ 1 SCHEME OF EXAMINATION Duration
More informationIntraoperative application of Cytosorb in cardiac surgery
Intraoperative application of Cytosorb in cardiac surgery Dr. Carolyn Weber Heart Center of the University of Cologne Dept. of Cardiothoracic Surgery Cologne, Germany SIRS & Cardiopulmonary Bypass (CPB)
More informationFrom Recovery to Transplant: One Patient's Journey
From Recovery to Transplant: One Patient's Journey Tonya Elliott, RN, MSN Assist Device and Thoracic Transplant Coordinator Inova Transplant Center at Inova Fairfax Hospital Falls Church, VA Introduction
More informationExpanding Horizons: AngioVac Suction Thrombectomy at UTHealth
Expanding Horizons: AngioVac Suction Thrombectomy at UTHealth Naveed Saqib, MD Assistant Professor Department of Cardiothoracic and Vascular Surgery McGovern Medical School The University of Texas Science
More informationGENERAL SURGICAL ADULT POST-OPERATIVE ORDERS 1 of 4
down ADULT POST-OPERATIVE 1 of 4 9 Actual 9 Estimated Patient ID Area Weight kg 9 Actual 9 Estimated Height cm ALLERGIES: REFER TO ALLERGY PROFILE/ POWERCHART Admit to: Post Anesthesia Care Unit (PACU),
More informationAssessment of Prospectivelv Randomized Patients Receiving hopran6101 Therapy before Coronary Bypass Operation
Assessment of Prospectivelv Randomized Patients Receiving hopran6101 Therapy before Coronary Bypass Operation Andrew S. Wechsler, M.D. ABSTRACT Fifty patients receiving propranolol were randomized into
More informationOptimizing Blood ManagementTM
Optimizing Blood ManagementTM A Multi-Strategy Approach to Controlling Inflammatory Response Terumo Introduces the Optimizing Blood Management Relationship Browser. For the full interactive experience,
More informationEffect of ACD Blood Prime on Plasma
Effect of ACD Blood Prime on Plasma Calcium and Magnesium Duncan A. Killen, M.D., Edwin L. Grogan, 11, M.D., Roland E. Gower, M.D., Isabella S. Collins, M.D., and Harold A. Collins, M.D. ABSTRACT The changes
More informationPerioperative Management of TAPVC
Perioperative Management of TAPVC Professor Andrew Wolf Rush University Medical Center,Chicago USA Bristol Royal Children s Hospital UK I have no financial disclosures relevant to this presentation TAPVC
More informationWHILE it is generally agreed that elevation
The Derivation of Coronary Sinus Flow During Elevation of Right Ventricular Pressure By HERMAN M. GELLER, B.S., M.D., MARTIN BRANDFONBRENEU, M.D., AND CARL J. WIGGERS, M.D., The derivation of coronary
More informationHydroxyethyl Starch versus Albumin in Cardiopulmonary Bypass Prime Solutions
Hydroxyethyl Starch versus Albumin in Cardiopulmonary Prime Solutions Craig R. Saunders, M.D., Louis Carlisle, R.N., and Rodger L. Bick, M.D. ABSTRACT To compare hydroxyethyl starch (HES) with 25% albumin,
More informationEvaluation of Central Venous Pressure as a Guide to Volume Replacement in Children Following Cardiopulmonary Bypass
Evaluation of Central Venous Pressure as a Guide to Volume Replacement in Children Following Cardiopulmonary Bypass Alan B. Gazzaniga, M.D., Charles L. Byrd, M.D., David R. Stewart, M.D., and Nicholas
More informationComparison of Tranexamic Acid and Aminocaproic Acid in Coronary Bypass Surgery
Butler Journal of Undergraduate Research Volume 2 Article 24 2016 Comparison of Tranexamic Acid and Aminocaproic Acid in Coronary Bypass Surgery Lisa K. LeCleir Butler University, lisa.lecleir@gmail.com
More informationConventional CABG Or On Pump Beating Heart: A Difference In Myocardial Injury?
Conventional CABG Or On Pump Beating Heart: A Difference In Myocardial Injury? Kornelis J. Koopmans Medical Center Leeuwarden Leeuwarden, The Netherlands I have no disclosures Disclosures Different techniques
More informationThinking outside of the box Perfusion management and myocardial protection strategy for a patient with sickle cell disease
Thinking outside of the box Perfusion management and myocardial protection strategy for a patient with sickle cell disease Shane Buel MS, RRT 1 Nicole Michaud MS CCP PBMT 1 Rashid Ahmad MD 2 1 Vanderbilt
More informationWhat would be the response of the sympathetic system to this patient s decrease in arterial pressure?
CASE 51 A 62-year-old man undergoes surgery to correct a herniated disc in his spine. The patient is thought to have an uncomplicated surgery until he complains of extreme abdominal distention and pain
More informationInhixa (Enoxaparin Sodium)
Inhixa (Enoxaparin Sodium) P R E V ENTIS SAFETY D E V I C E P R E V E N T I S I S A N AU TO M AT I C N E E D L E S H I E L D I N G S Y S T E M, W H I C H H A S A C O V E R T H AT E X T E N D S O V E R
More informationHypovolemic Shock: Regulation of Blood Pressure
CARDIOVASCULAR PHYSIOLOGY 81 Case 15 Hypovolemic Shock: Regulation of Blood Pressure Mavis Byrne is a 78-year-old widow who was brought to the emergency room one evening by her sister. Early in the day,
More informationin In traoperative Heparin Reversal
Use of the Activated Coagulation Time in In traoperative Heparin Reversal for Cardiopulmonary Operations ' Kenneth L. Mattox, M.D., Gene A. Guinn, M.D., Pedro A. Rubio, M.D., and Arthur C. Beall, Jr.,
More informationFAILURE IN PATIENTS WITH MYOCARDIAL INFARCTION
Br. J. clin. Pharmac. (1982), 14, 187S-19lS BENEFICIAL EFFECTS OF CAPTOPRIL IN LEFT VENTRICULAR FAILURE IN PATIENTS WITH MYOCARDIAL INFARCTION J.P. BOUNHOURE, J.G. KAYANAKIS, J.M. FAUVEL & J. PUEL Departments
More informationKevin K. Nunnink Extracorporeal Membrane Oxygenation Program
PATIE NT I N FO R M ATI O N Kevin K. Nunnink Extracorporeal Membrane Oxygenation Program A family s guide to understanding this specialized treatment for cardiac and pulmonary complications Saint Luke
More information2.5 Other Hematology Consult:
The Warfarin Order Sheet has been approved by the P & T committee to be implemented by pharmacists. These orders are not used to treat patients with serious hemorrhagic complications. WARFARIN TARGET INR
More informationISPUB.COM. Concepts Of Neonatal ECMO. D Thakar, A Sinha, O Wenker HISTORY PATIENT SELECTION AND ECMO CRITERIA
ISPUB.COM The Internet Journal of Emergency and Intensive Care Medicine Volume 5 Number 2 D Thakar, A Sinha, O Wenker Citation D Thakar, A Sinha, O Wenker.. The Internet Journal of Emergency and Intensive
More informationPlatelet Dysfunction Associated with Cardiopulmonary Bypass
Platelet Dysfunction Associated with Cardiopulmonary Bypass William R. Friedenberg, M.D., William 0. Myers, M.D., Edward D. Plotka, Ph.D., James N. Beathard, P.A., Daniel J. Kummer, P.A., Patience F. Gatlin,
More informationFresh and Citrated Whole-Blood Specimens Can Produce Different Thromboelastography Results in Patients on Extracorporeal Membrane Oxygenation
Fresh and Citrated Whole-Blood Specimens Can Produce Different Thromboelastography Results in Patients on Extracorporeal Membrane Oxygenation Elizabeth A. Gilman, MD, 1 Christopher D. Koch, 1 Paula J.
More informationControl of blood tissue blood flow. Faisal I. Mohammed, MD,PhD
Control of blood tissue blood flow Faisal I. Mohammed, MD,PhD 1 Objectives List factors that affect tissue blood flow. Describe the vasodilator and oxygen demand theories. Point out the mechanisms of autoregulation.
More informationOPCAB IS NOT BETTER THAN CONVENTIONAL CABG
OPCAB IS NOT BETTER THAN CONVENTIONAL CABG Harold L. Lazar, M.D. Harold L. Lazar, M.D. Professor of Cardiothoracic Surgery Boston Medical Center and the Boston University School of Medicine Boston, MA
More informationPhysiological Response to Hypovolemic Shock Dr Khwaja Mohammed Amir MD Assistant Professor(Physiology) Objectives At the end of the session the
Physiological Response to Hypovolemic Shock Dr Khwaja Mohammed Amir MD Assistant Professor(Physiology) Objectives At the end of the session the students should be able to: List causes of shock including
More informationAmphotericin B Pharmacokinetics During Extracorporea/ Membrane Oxygenation: A Case Report
Case Report Amphotericin B Pharmacokinetics During Extracorporea/ Membrane Oxygenation: A Case Report James H. Hertzog, MD; Ellen Brackett, MD; Mark Sale, MD; Gabriel J. Hauser, MD; Heidi J. Dalton, MD
More informationImpact of a Phosphorylcholine-Coated Cardiac Bypass Circuit on Blood Loss and Platelet Function: A Prospective, Randomized Study
The Journal of ExtraCorporeal Technology Original Articles Impact of a Phosphorylcholine-Coated Cardiac Bypass Circuit on Blood Loss and Platelet Function: A Prospective, Randomized Study Sandrine Marguerite,
More information612.I73:6I2.I3. mammary and mediastinal vessels tied off. The thoracic wall on the left
612.I73:6I2.I3 CARDIAC OUTPUT AND BLOOD DISTRIBUTION. By H. BAR CROFT (Harmsworth Scholar, St Mary's Hospital, London). (From the Physiological Laboratory, Cambridge.) THE methods for the measurement of
More informationIncidence and pattern of Thrombocytopenia in cardiac surgery patients
1019 ORIGINAL ARTICLE Incidence and pattern of Thrombocytopenia in cardiac surgery patients Mohammad Hamid, Mohammad Irfan Akhtar, Hamid Iqil Naqvi, Khalid Ahsan Abstract Objective: To observe the incidence
More informationValue of serum magnesium estimation in diagnosing myocardial infarction and predicting dysrhythmias after coronary artery bypass grafting
Thorax 1983;38:946-95 Value of serum magnesium estimation in diagnosing myocardial infarction and predicting dysrhythmias after coronary artery bypass grafting RICHARD W BUNTON From the Department of Cardiothoracic
More informationPlasma Triglyceride Concentration and Plasma Free
Journal of Clinical Investigation Vol. 3, No. 1, 196 Plasma Triglyceride Concentration and Plasma Free Fatty Acid Changes in Response to Norepinephrine in Man * (From the University of Melbourne Department
More informationPreparing for Patients at High Risk of Transfusion
18/10/2017 Preparing for Patients at High Risk of Transfusion Jane Ottens. B.Sc., CCP ( Aust) Ashford Hospital, South Australia Preparing for Patients at High Risk of Transfusion Jane Ottens. B.Sc., CCP
More informationInterrelationship between Angiotensin Catecholamines. Tatsuo SATO, M.D., Masaru MAEBASHI, M.D., Koji GOTO, M.D., and Kaoru YOSHINAGA, M.D.
Interrelationship between Angiotensin and Catecholamines Tatsuo SATO, M.D., Masaru MAEBASHI, M.D., Koji GOTO, M.D., and Kaoru YOSHINAGA, M.D. SUMMARY Urinary catecholamines were measured with an attempt
More informationClinical Evaluation of Priming Solutions for Pump Oxygenator Perfusion
.. Clinical Evaluation of Priming Solutions for Pump Oxygenator Perfusion William H. Lee, Jr., M.D., Joseph W. Rubin, M.D., and Mary P. Huggins, B.S. ABSTRACT Various hemodilution agents are now used routinely
More informationMayor lung resection in the presence of anti-platelet therapy. Hans-Beat Ris Service de Chirurgie Thoracique CHUV, Lausanne
Mayor lung resection in the presence of anti-platelet therapy Hans-Beat Ris Service de Chirurgie Thoracique CHUV, Lausanne THORACIC SURGERY IN THE PRESENCE OF ANTI-PLATELET THERAPY Charybdis: Thrombosis
More informationCost-effectiveness of minimally invasive coronary artery bypass surgery Arom K V, Emery R W, Flavin T F, Petersen R J
Cost-effectiveness of minimally invasive coronary artery bypass surgery Arom K V, Emery R W, Flavin T F, Petersen R J Record Status This is a critical abstract of an economic evaluation that meets the
More informationPerioperative Management of DORV Case
Perioperative Management of DORV Case James P. Spaeth, MD Department of Anesthesia Cincinnati Children s Hospital Medical Center University of Cincinnati Objectives: 1. Discuss considerations regarding
More informationEffective Date: Approved by: Laboratory Director, Jerry Barker (electronic signature)
1 of 5 Policy #: 702 (PHL-702-05) Effective Date: 9/30/2004 Reviewed Date: 8/1/2016 Subject: TRANSFUSION GUIDELINES Approved by: Laboratory Director, Jerry Barker (electronic signature) Approved by: Laboratory
More informationAcute Kidney Injury after Cardiac Surgery: Incidence, Risk Factors and Prevention
Acute Kidney Injury after Cardiac Surgery: Incidence, Risk Factors and Prevention Hong Liu, MD Professor of Clinical Anesthesiology Department of Anesthesiology and Pain Medicine University of California
More informationJournal of the American College of Cardiology Vol. 33, No. 6, by the American College of Cardiology ISSN /99/$20.
Journal of the American College of Cardiology Vol. 33, No. 6, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00061-3 for Prediction
More informationUniversity of Pennsylvania Health System Aprotinin Task Force
Aprotinin Use in Adult Cardiac Surgery: A Recommendation Statement from the University of Pennsylvania Health System Center for Evidence-based Practice *Note: This guideline was originally released on
More informationby Starling [1914] and Daly [1925].
612.13 PROPERTIES OF THE PERIPHERAL VASCULAR SYSTEM AND THEIR RELATION TO THE SYSTEMIC OUTPUT. BY HENRY BARCROFT. Harmsworth Scholar, St Mary's Hospital, London. (Experiments performed in the Physiological
More informationADULT CARDIAC SURGERY TELEMETRY BED TRANSFER ORDERS 1 of 4
ADULT CARDIAC SURGERY TELEMETRY BED TRANSFER 1 of 4 9 Actual 9 Estimated Attending Surgeon: Medical Record Number Weight kg 9 Actual 9 Estimated Height cm ALLERGIES: REFER TO ALLERGY PROFILE/ POWERCHART
More informationImages have been removed from the PowerPoint slides in this handout due to copyright restrictions.
Percutaneous Coronary Intervention https://www.youtube.com/watch?v=bssqnhylvma Types of PCI Procedures Balloon Angioplasty Rotational Atherectomy Coronary Stent Balloon Inflation Rotational Atherectomy
More informationNothing to Disclose. Severe Pulmonary Hypertension
Severe Ronald Pearl, MD, PhD Professor and Chair Department of Anesthesiology Stanford University Rpearl@stanford.edu Nothing to Disclose 65 year old female Elective knee surgery NYHA Class 3 Aortic stenosis
More information